Cargando…

Update on Novel Therapeutics for Primary CNS Lymphoma

SIMPLE SUMMARY: Primary central nervous system lymphoma is a rare and aggressive form of non-Hodgkin lymphoma. While it is highly responsive to first-line chemo and radiation treatments, rates of relapse are high, demonstrating the need for improved therapeutic strategies. Recent advancements in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaff, Lauren R., Grommes, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582401/ https://www.ncbi.nlm.nih.gov/pubmed/34771535 http://dx.doi.org/10.3390/cancers13215372

Ejemplares similares

SL3 PRIMARY CNS LYMPHOMA: CURRENT CONCEPTS AND THERAPEUTIC PERSPECTIVES
por: Grommes, Christian
Publicado: (2019)

Is more better? Increased doses of high dose methotrexate and addition of rituximab is associated with improved outcomes in a large primary CNS lymphoma cohort
por: Yerram, Prakirthi, et al.
Publicado: (2023)

COVD-23. PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
por: Schaff, Lauren, et al.
Publicado: (2020)

Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies
por: Schaff, Lauren R., et al.
Publicado: (2021)

PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
por: Schaff, L., et al.
Publicado: (2022)

An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
por: Scheichel, Florian, et al.
Publicado: (2022)

PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA
por: Soussain, C., et al.
Publicado: (2022)

Primary CNS Lymphoma
por: Phillips, Elizabeth H., et al.
Publicado: (2014)

Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring
por: Chiavazza, C., et al.
Publicado: (2018)

Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
por: Prodduturi, Prathima, et al.
Publicado: (2012)

Primary CNS lymphoma: latest updates and a 10-year monocenter experience
por: Cencini, Emanuele, et al.
Publicado: (2018)

CLRM-15 TRIAL IN PROGRESS: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT INHIBITOR OF BRUTON’S TYROSINE KINASE (BTKI) FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA (R/R PCNSL/SCNSL) AND PRIMARY VITREORETINAL LYMPHOMA (PVRL)
por: Soussain, Carole, et al.
Publicado: (2022)

Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
por: Seidel, Clemens, et al.
Publicado: (2021)

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study
por: Schaff, Lauren R., et al.
Publicado: (2022)

Updates on Molecular Targeted Therapies for Intraparenchymal CNS Metastases
por: Sharma, Akanksha, et al.
Publicado: (2021)

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2021)

An audit on the diagnosis of primary CNS lymphoma
por: Joe, Dorothy, et al.
Publicado: (2021)

Primary CNS Lymphoma Masquerading as Ventriculitis
por: Rohatgi, Shalesh, et al.
Publicado: (2022)

Diagnosis and management of primary intraocular lymphoma: an update
por: Jahnke, Kristoph, et al.
Publicado: (2007)

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)
por: Barajas, Ramon F, et al.
Publicado: (2021)

Relapse pattern and prognosis of primary CNS lymphoma
por: Dahiya, Saurabh, et al.
Publicado: (2012)

Expression of Tim‐1 in primary CNS lymphoma
por: Kishimoto, Wataru, et al.
Publicado: (2016)

Sex-Specific Differences in Primary CNS Lymphoma
por: Roetzer, Thomas, et al.
Publicado: (2020)

Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma
por: Heming, Michael, et al.
Publicado: (2022)

CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
por: Karschnia, Philipp, et al.
Publicado: (2021)

Multiparametric MR Imaging Features of Primary CNS Lymphomas
por: Talybov, Rustam, et al.
Publicado: (2022)

IL-4 CHALLENGES FOR MANAGEMENT OF PRIMARY CNS LYMPHOMA
por: Nagane, Motoo
Publicado: (2022)

An update on the CNS manifestations of neurofibromatosis type 2
por: Coy, Shannon, et al.
Publicado: (2019)

Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies
por: Holdhoff, Matthias, et al.
Publicado: (2020)

CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers
por: Mizutani, Hironori, et al.
Publicado: (2018)

Sentinel inflammatory demyelinating lesions preceding primary CNS lymphoma
por: TORRES, Danielle Mesquita, et al.
Publicado: (2021)

MRI Findings of Primary CNS Lymphoma in 26 Immunocompetent Patients
por: Zhang, Dong, et al.
Publicado: (2010)

Relapse pattern and prognostic factors for patients with primary CNS lymphoma
por: Suh, Cheolwon, et al.
Publicado: (2012)

Primary CNS lymphoma commonly expresses immune response biomarkers
por: Ou, Alexander, et al.
Publicado: (2020)

Therapeutic Updates for Relapsed and Refractory Classical Hodgkin Lymphoma
por: Voorhees, Timothy J, et al.
Publicado: (2020)

Hypertrophic multiple cranial neuropathies: An unusual presentation of primary CNS lymphoma
por: Khadilkar, Satish V., et al.
Publicado: (2015)

Use of circulating tumor DNA to guide treatment of primary central nervous system lymphoma: a case report
por: Ho, Ka-wai Grace, et al.
Publicado: (2021)

Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—a narrative review
por: Krebs, Simone, et al.
Publicado: (2021)

Micro RNAs as a Diagnostic Marker between Glioma and Primary CNS Lymphoma: A Systematic Review
por: Dabbagh Ohadi, Mohammad Amin, et al.
Publicado: (2023)

Primary B Cell Lymphoma of the CNS Mimicking Anti-LGI1 Limbic Encephalitis
por: Thomas, Christian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_igpiksd1g3vveu6m8bphfj8cm1